<?xml version='1.0' encoding='Windows-1252'?>
<rss version='2.0'>
  <channel>
    <title>Pharmaceuticals - Medical News</title>
    <link>http://medical.presslib.com/pharmaceuticals/index.htm</link>
    <description>Pharmaceuticals headlines posted throughout the day, every day.</description>



    <pubDate>Sun, 18 Jan 2009 04:25:39 -0800</pubDate>
    <lastBuildDate>Sun, 18 Jan 2009 04:25:39 -0800</lastBuildDate>
	 <docs>http://blogs.law.harvard.edu/tech/rss/</docs>
	 <ttl>60</ttl>
    <item>
      <guid isPermaLink="true">http://medical.presslib.com/pharmaceuticals/1876444.htm</guid>
      <link>http://medical.presslib.com/pharmaceuticals/1876444.htm</link>
      <pubDate>Sun, 18 Jan 2009 04:25:39 -0800</pubDate>
      <title>Recent Advances in Organic Chemistry Using Real-Time In Situ FTIR</title>
      <description>Organic Chemistry case studies illustrating the value of in situ mid IR reaction monitoring for facilitating a fundamental knowledge of chemical reactions</description>
      <category domain="http://medical.presslib.com/pharmaceuticals/index.htm">Pharmaceuticals</category>
    </item>
    <item>
      <guid isPermaLink="true">http://medical.presslib.com/pharmaceuticals/1877144.htm</guid>
      <link>http://medical.presslib.com/pharmaceuticals/1877144.htm</link>
      <pubDate>Fri, 16 Jan 2009 16:43:13 -0800</pubDate>
      <title>Law Firm Freedland Russo Spearheads Record-Setting Whistleblower Case Against Pharmaceutical Giant Eli Lilly -- Firm Expands Offices to Include L.A. Entertainment Branch</title>
      <description>Florida based law firm of Freedland Russo publicly revealed the law firm that initiated the nation&amp;#039;s largest federal whistleblower case to date, which was unsealed in Philadelphia on Thursday, January 15. As part of a settlement with the U.S. Attorney&amp;#039;s Office, Eli Lilly &amp; Company will pay out $1.4 billion in civil and criminal fines related to its illegal and fraudulent marketing of the highly profitable prescription drug Zyprexa.</description>
      <category domain="http://medical.presslib.com/pharmaceuticals/index.htm">Pharmaceuticals</category>
    </item>
    <item>
      <guid isPermaLink="true">http://medical.presslib.com/pharmaceuticals/1866304.htm</guid>
      <link>http://medical.presslib.com/pharmaceuticals/1866304.htm</link>
      <pubDate>Thu, 15 Jan 2009 13:03:10 -0800</pubDate>
      <title>ClearTrial to Provide Guidelines for Accurately Forecasting and Budgeting Adaptive Clinical Trials at CBI Conference</title>
      <description>ClearTrial will examine solutions to the budgeting, forecasting, and operational planning challenges presented by adaptive studies. These challenges include creating multiple and varied trial scenarios accounting for shifting resource allocations, timelines, treatment arms, and more.</description>
      <category domain="http://medical.presslib.com/pharmaceuticals/index.htm">Pharmaceuticals</category>
    </item>
    <item>
      <guid isPermaLink="true">http://medical.presslib.com/pharmaceuticals/1866914.htm</guid>
      <link>http://medical.presslib.com/pharmaceuticals/1866914.htm</link>
      <pubDate>Thu, 15 Jan 2009 13:03:09 -0800</pubDate>
      <title>360e Productions Advances While Production Agency Conglomerates Struggle</title>
      <description>This is a difficult economy, no doubt, but 360e Production&amp;#039;s virtual, open business model proves to be an aggressively progressive new approach that is solid and successful, despite industry challenges, translating to value for clients.</description>
      <category domain="http://medical.presslib.com/pharmaceuticals/index.htm">Pharmaceuticals</category>
    </item>
    <item>
      <guid isPermaLink="true">http://medical.presslib.com/pharmaceuticals/1868364.htm</guid>
      <link>http://medical.presslib.com/pharmaceuticals/1868364.htm</link>
      <pubDate>Thu, 15 Jan 2009 03:16:20 -0800</pubDate>
      <title>SARMs... The Benefits Of Anabolic Steroids, Without The Common Side Effects, Without Being Detected</title>
      <description>While they&amp;#039;re banned by several doping agencies, most athletes have never heard of them.  Selective Androgen Receptor Modulators (SARMs), which are currently undetectable, may be the performance enhancers of the future.</description>
      <category domain="http://medical.presslib.com/pharmaceuticals/index.htm">Pharmaceuticals</category>
    </item>
    <item>
      <guid isPermaLink="true">http://medical.presslib.com/pharmaceuticals/1867414.htm</guid>
      <link>http://medical.presslib.com/pharmaceuticals/1867414.htm</link>
      <pubDate>Thu, 15 Jan 2009 03:16:20 -0800</pubDate>
      <title>Teledyne Tekmar Welcomes SCI-CON to its Family</title>
      <description>Teledyne Tekmar Company, a subsidiary of Teledyne Technologies Incorporated (NYSE:TDY) announces their latest sales partnership.</description>
      <category domain="http://medical.presslib.com/pharmaceuticals/index.htm">Pharmaceuticals</category>
    </item>
    <item>
      <guid isPermaLink="true">http://medical.presslib.com/pharmaceuticals/1854574.htm</guid>
      <link>http://medical.presslib.com/pharmaceuticals/1854574.htm</link>
      <pubDate>Wed, 14 Jan 2009 07:22:59 -0800</pubDate>
      <title>Ash Stevens Enhances Speed and Safety of Scale-Up with New Investments in Parallel Synthesis and Calorimetry Instrumentation</title>
      <description>Ash Stevens Incorporated (ASI), a full service cGMP contract manufacturer, enhanced the speed and safety of scale-up with new investments in parallel synthesis and calorimetry instrumentation at its Riverview, Michigan Active Pharmaceutical Ingredient (API) development and manufacturing site.</description>
      <category domain="http://medical.presslib.com/pharmaceuticals/index.htm">Pharmaceuticals</category>
    </item>
    <item>
      <guid isPermaLink="true">http://medical.presslib.com/pharmaceuticals/1859604.htm</guid>
      <link>http://medical.presslib.com/pharmaceuticals/1859604.htm</link>
      <pubDate>Wed, 14 Jan 2009 05:12:05 -0800</pubDate>
      <title>The Deal Magazine&#039;s Deal Economy Preview Reveals Pressure Centers in Today&#039;s Rapidly Changing Market</title>
      <description>The magazine&#039;s cover story examines how the woes of residential real estate may soon be joined
by their brethren on the commercial side</description>
      <category domain="http://medical.presslib.com/pharmaceuticals/index.htm">Pharmaceuticals</category>
    </item>
    <item>
      <guid isPermaLink="true">http://medical.presslib.com/pharmaceuticals/1855114.htm</guid>
      <link>http://medical.presslib.com/pharmaceuticals/1855114.htm</link>
      <pubDate>Tue, 13 Jan 2009 13:36:23 -0800</pubDate>
      <title>Liaison Technologies Strengthens Its Presence in Europe with New Subsidiaries</title>
      <description>Liaison Technologies, a global provider of integration and data management services, announced today the expansion of its European operations to the UK and Sweden, where the company is opening new subsidiaries. The European business integration and data management service market is growing fast and the UK and Sweden are key markets for Liaison. Setting up new subsidiaries is an important step for the expansion of Liaison&amp;#039;s European and international operations. The company already has offices in Finland and the Netherlands as well as significant coverage in US markets with global headquarters in Atlanta, GA.</description>
      <category domain="http://medical.presslib.com/pharmaceuticals/index.htm">Pharmaceuticals</category>
    </item>
    <item>
      <guid isPermaLink="true">http://medical.presslib.com/pharmaceuticals/1856044.htm</guid>
      <link>http://medical.presslib.com/pharmaceuticals/1856044.htm</link>
      <pubDate>Tue, 13 Jan 2009 05:24:57 -0800</pubDate>
      <title>Datafarm, Inc., Announces the Appointment of Daniel F. Orfe to Vice President, Global Regulatory Submission Services</title>
      <description>Datafarm, Inc. a leading provider of Electronic Document Publishing Solutions and Regulatory Submissions Services for the Life Sciences Industry, is pleased to announce the appointment of Mr. Daniel F. Orfe to Vice President, Global Regulatory Submission Services (GRSS).  In this role, Mr. Orfe will oversee Datafarm&amp;#039;s Regulatory Services Group.</description>
      <category domain="http://medical.presslib.com/pharmaceuticals/index.htm">Pharmaceuticals</category>
    </item>
  </channel>
</rss>
